Cargando…
Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis
BACKGROUND: Owing to reports of recurrent cardiac events in some catecholaminergic polymorphic ventricular tachycardia (CPVT) patients using β-blockers, safer alternatives are being investigated. Flecainide is an alternative adjunctive anti-arrhythmic agent known to provide incomplete protection to...
Autores principales: | Wang, Guangqiang, Zhao, Na, Zhong, Shu, Wang, Yingrong, Li, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716729/ https://www.ncbi.nlm.nih.gov/pubmed/31441899 http://dx.doi.org/10.1097/MD.0000000000016961 |
Ejemplares similares
-
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
por: Li, Yukun, et al.
Publicado: (2022) -
Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia
por: Davidson, Ross, et al.
Publicado: (2023) -
Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
por: Williams, Alan J., et al.
Publicado: (2016) -
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
por: Hwang, Hyun Seok, et al.
Publicado: (2019) -
Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018)